Food & Drug Administration (FDA) announced it will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23 and 24, 2026, to discuss permitting compounding pharmacies to prepare certain peptides used for ulcerative colitis (UC), wound healing, obesity, insomnia, opioid withdrawal, inflammatory conditions, and osteoporosis, among other conditions
PMID: 41155448 Int J Mol SciFisetin Attenuates Zinc Overload-Induced Hepatotoxicity in Mice via Autophagy-Dependent Nrf2 Activation
Concerns were also raised regarding long-term systemic activation, which may affect reproductive function, bone turnover, and immune regulation
Do oral peptides need the same storage care
Treatment Protocols and Monitoring Regardless of which path you choose, ongoing monitoring ensures safety and optimizes results